切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2025, Vol. 19 ›› Issue (04) : 521 -527. doi: 10.3877/cma.j.issn.1674-3253.2025.04.020

所属专题: 文献

综述

肾门肿瘤的肾部分切除术的手术选择和技术改良
罗瑞翔, 周祥福()   
  1. 510530 广州,中山大学附属第三医院岭南院区泌尿外科
  • 收稿日期:2023-11-01 出版日期:2025-08-01
  • 通信作者: 周祥福
  • 基金资助:
    国家自然科学基金面上项目(82170786); 2022年中山三院临床研究专项基金远航计划资助项目(YHJH202205); 广州市科技计划项目重点研发计划(202103000035); 广州地区临床特色技术(2023P-TS34)

Surgical selection and technical improvement of partial nephrectomy for renal hilum tumors

Ruixiang Luo, Xiangfu Zhou()   

  1. Department of Urology, the Third Affiliated Hospital of Sun Yat-sen University Lingnan Hospital, Guangzhou 510530, China
  • Received:2023-11-01 Published:2025-08-01
  • Corresponding author: Xiangfu Zhou
引用本文:

罗瑞翔, 周祥福. 肾门肿瘤的肾部分切除术的手术选择和技术改良[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(04): 521-527.

Ruixiang Luo, Xiangfu Zhou. Surgical selection and technical improvement of partial nephrectomy for renal hilum tumors[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(04): 521-527.

肾部分切除术目前已被各大指南推荐为T1a期肾肿瘤的优先术式,而肾门肿瘤由于其临近肾血管及肾集合系统的特殊解剖学位置,对于肾门肿瘤的肾部分切除术,一直以来都被公认为是泌尿外科富有挑战性的手术。本文总结了该术式的手术技巧及经验,认为通过完善的术前评估,合适手术入路的选择,肿瘤切除及创面重建技巧的改良,可安全有效地完成手术,达到切缘阴性、缩短热缺血时间、减少围术期并发症的"三连胜"目标。

Partial nephrectomy has been recommended by various guidelines as the preferred surgical procedure for T1a stage renal tumors. However, due to its special anatomical location near renal blood vessels and the renal collecting system, partial nephrectomy for renal portal tumors has always been recognized as a challenging surgery in Urology. This article summarizes the surgical techniques and experience of this procedure, and believes that through comprehensive preoperative evaluation, appropriate surgical approach selection, improved tumor resection and wound reconstruction techniques, the surgery can be safely and effectively completed, achieving the "three consecutive victories" goal of negative margins, shortened ischemia time, and reduced perioperative complications.

[1]
Bukavina L, Bensalah K, Bray F, et al. Epidemiology of renal cell carcinoma: 2022 update[J]. Eur Urol, 2022, 82(5): 529-542. DOI: 10.1016/j.eururo.2022.08.019.
[2]
Bahadoram S, Davoodi M, Hassanzadeh S, et al. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment[J]. G Ital Nefrol, 2022, 39(3): 2022-vol3.
[3]
Garisto J, Bertolo R, Dagenais J, et al. Robotic versus open partial nephrectomy for highly complex renal masses: comparison of perioperative, functional, and oncological outcomes[J]. Urol Oncol Semin Orig Investig, 2018, 36(10): 471.e1-471.e9. DOI: 10.1016/j.urolonc.2018.06.012.
[4]
Bhindi B, Lohse CM, Schulte PJ, et al. Predicting renal function outcomes after partial and radical nephrectomy[J]. Eur Urol, 2019, 75(5): 766-772. DOI: 10.1016/j.eururo.2018.11.021.
[5]
Ochoa-Arvizo M, García-Campa M, Santos-Santillana KM, et al. Renal functional and cardiovascular outcomes of partial nephrectomy versus radical nephrectomy for renal tumors: a systematic review and meta-analysis[J]. Urol Oncol, 2023, 41(3): 113-124. DOI: 10.1016/j.urolonc.2022.11.024.
[6]
Flegar L, Groeben C, Koch R, et al. Trends in renal tumor surgery in the United States and Germany between 2006 and 2014: organ preservation rate is improving[J]. Ann Surg Oncol, 2020, 27(6): 1920-1928. DOI: 10.1245/s10434-019-08108-x.
[7]
Liu T, Zhao Z, Feng B, et al. Robotic-assisted laparoscopic tumor enucleation is a feasible technique for renal hilar tumors: a retrospective study[J]. J Surg Oncol, 2021, 124(1): 135-142. DOI: 10.1002/jso.26479.
[8]
Alvim RG, Tin AL, Nogueira L, et al. Functional and oncological outcomes of renal surgery for hilar tumors: informing the decisions in risk-adapted management[J]. Urology, 2021, 157: 174-180. DOI: 10.1016/j.urology.2021.07.014.
[9]
Furukawa J, Kanayama H, Azuma H, et al. 'Trifecta’ outcomes of robot-assisted partial nephrectomy: a large Japanese multicenter study[J]. Int J Clin Oncol, 2020, 25(2): 347-353. DOI: 10.1007/s10147-019-01565-0.
[10]
Gill IS, Colombo JR Jr, Frank I, et al. Laparoscopic partial nephrectomy for hilar tumors[J]. J Urol, 2005, 174(3): 850-853; discussion 853-854. DOI: 10.1097/01.ju.0000169493.05498.c3.
[11]
Reisiger K, Venkatesh R, Figenshau RS, et al. Complex laparoscopic partial nephrectomy for renal hilar tumors[J]. Urology, 2005, 65(5): 888-891. DOI: 10.1016/j.urology.2004.11.026.
[12]
Sunaryo PL, Paulucci DJ, Okhawere K, et al. A multi-institutional analysis of 263 hilar tumors during robot-assisted partial nephrectomy[J]. J Robot Surg, 2020, 14(4): 585-591. DOI: 10.1007/s11701-019-01028-8.
[13]
Wang F, Zhang C, Guo F, et al. Navigation of intelligent/interactive qualitative and quantitative analysis three-dimensional reconstruction technique in laparoscopic or robotic assisted partial nephrectomy for renal hilar tumors[J]. J Endourol, 2019, 33(8): 641-646. DOI: 10.1089/end.2018.0570.
[14]
Carlier M, Lareyre F, CD, et al. A pilot study investigating the feasibility of using a fully automatic software to assess the RENAL and PADUA score[J]. Progrès En Urol, 2022, 32(8-9): 558-566. DOI: 10.1016/j.purol.2022.04.001.
[15]
Jin D, Zhang J, Zhang Y, et al. A combination of the mayo adhesive probability score and the RENAL score to predict intraoperative complications in small renal masses[J]. Urol Int, 2020, 104(1-2): 142-147. DOI: 10.1159/000504767.
[16]
Weprin S, Falagario U, Veccia A, et al. Simplified PADUA renal (SPARE) nephrometry scoring system: external validation, interobserver variability, and comparison with RENAL and PADUA in a single-center robotic partial nephrectomy series[J]. Eur Urol Focus, 2021, 7(3): 591-597. DOI: 10.1016/j.euf.2020.05.016.
[17]
Simmons MN, Ching CB, Samplaski MK, et al. Kidney tumor location measurement using the C index method[J]. J Urol, 2010, 183(5): 1708-1713. DOI: 10.1016/j.juro.2010.01.005.
[18]
Huang Q, Gu L, Zhu J, et al. A three-dimensional, anatomy-based nephrometry score to guide nephron-sparing surgery for renal sinus tumors[J]. Cancer, 2020, 126(Suppl 9): 2062-2072. DOI: 10.1002/cncr.32748.
[19]
Davidiuk AJ, Parker AS, Thomas CS, et al. Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomy[J]. Eur Urol, 2014, 66(6): 1165-1171. DOI: 10.1016/j.eururo.2014.08.054.
[20]
Tsai SH, Tseng PT, Sherer BA, et al. Open versus robotic partial nephrectomy: systematic review and meta-analysis of contemporary studies[J]. Int J Med Robot, 2019, 15(1): e1963. DOI: 10.1002/rcs.1963.
[21]
Antonelli JA, Bagrodia A, Odom C, et al. Laparoendoscopic single-site nephrectomy compared with conventional laparoscopic nephrectomy: a 5-year, single-surgeon experience[J]. Eur Urol, 2013, 64(3): 412-418. DOI: 10.1016/j.eururo.2013.04.013.
[22]
张道远, 陆正, 陆伟, 等. 单孔与传统后腹腔镜肾癌根治术的比较研究[J]. 临床泌尿外科杂志, 2020, 35(3): 220-223. DOI: 10.13201/j.issn.1001-1420.2020.03.013.
[23]
Chen L, Deng W, Luo Y, et al. Comparison of robot-assisted and laparoscopic partial nephrectomy for renal hilar tumors: results from a tertiary referral center[J]. J Endourol, 2022, 36(7): 941-946. DOI: 10.1089/end.2020.0151.
[24]
Bao X, Dong W, Wang J, et al. Robot-assisted versus conventional laparoscopic partial nephrectomy for renal hilar tumors: Parenchymal preservation and functional recovery[J]. Int J Urol, 2022, 29(10): 1188-1194. DOI: 10.1111/iju.14968.
[25]
Hinata N, Shiroki R, Tanabe K, et al. Robot-assisted partial nephrectomy versus standard laparoscopic partial nephrectomy for renal hilar tumor: a prospective multi-institutional study[J]. Int J Urol, 2021, 28(4): 382-389. DOI: 10.1111/iju.14469.
[26]
Yang C, Wang Z, Huang S, et al. Retroperitoneal laparoscopic partial nephrectomy versus radical nephrectomy for clinical T1 renal hilar tumor: comparison of perioperative characteristics and short-term functional and oncologic outcomes[J]. J Laparoendosc Adv Surg Tech A, 2018, 28(10): 1183-1187. DOI: 10.1089/lap.2018.0064.
[27]
Grosso AA, Lambertini L, Di Maida F, et al. Three-dimensional reconstruction and intraoperative ultrasonography: crucial tools to safely approach highly complex renal masses[J]. Int Braz J Urol, 2022, 48(6): 996-997. DOI: 10.1590/S1677-5538.IBJU.2022.0224.
[28]
Aggarwal A, Goswami S, Das CJ. Contrast-enhanced ultrasound of the kidneys: principles and potential applications[J]. Abdom Radiol (NY), 2022, 47(4): 1369-1384. DOI: 10.1007/s00261-022-03438-z.
[29]
Soga N, Inoko A, Furusawa J, et al. Evaluation to differentiate between tumor lesions and the parenchyma in partial nephrectomies for renal tumors based on quantitative fluorescence imaging using indocyanine green dye[J]. Curr Urol, 2019, 13(2): 74-81. DOI: 10.1159/000499289.
[30]
张树栋, 洪鹏, 王滨帅, 等. 吲哚菁绿标记的荧光实时显影技术在腹腔镜肾部分切除术中的应用[J]. 北京大学学报(医学版), 2020, 52(4): 657-662. DOI: 10.19723/j.issn.1671-167X.2020.04.011.
[31]
Bertolo R, Autorino R, Fiori C, et al. Expanding the indications of robotic partial nephrectomy for highly complex renal tumors: urologists' perception of the impact of hyperaccuracy three-dimensional reconstruction[J]. J Laparoendosc Adv Surg Tech A, 2019, 29(2): 233-239. DOI: 10.1089/lap.2018.0486.
[32]
温星桥, 祝炜安, 王喻, 等. DVPV系统三维影像及虚拟现实导航在泌尿外科复杂手术的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(2): 91-95. DOI: 10.3877/cma.j.issn.1674-3253.2020.02.004.
[33]
武鹏, 杨晓剑, 王延柱, 等. 混合现实技术联合达芬奇机器人在完全内生型肾肿瘤行肾部分切除术中的临床应用[J]. 微创泌尿外科杂志, 2018, 7(4): 225-229. DOI: 10.19558/j.cnki.10-1020/r.2018.04.003.
[34]
Brassetti A, Cacciamani GE, Mari A, et al. On-clamp vs. off-clamp robot-assisted partial nephrectomy for cT2 renal tumors: retrospective propensity-score-matched multicenter outcome analysis[J]. Cancers (Basel), 2022, 14(18): 4431. DOI: 10.3390/cancers14184431.
[35]
Huang Y, Cao D, Chen Z, et al. Comparison of perioperative, renal functional, and oncological outcomes between off-clamp and on-clamp robot-assisted partial nephrectomy for renal tumors: an updated evidence-based analysis[J]. Front Oncol, 2021, 11: 730662. DOI: 10.3389/fonc.2021.730662.
[36]
Houston Thompson R, Lane BR, Lohse CM, et al. Every minute counts when the renal hilum is clamped during partial nephrectomy[J]. Eur Urol, 2010, 58(3): 340-345. DOI: 10.1016/j.eururo.2010.05.047.
[37]
Antonelli A, Cindolo L, Sandri M, et al. Is off-clamp robot-assisted partial nephrectomy beneficial for renal function?Data from the CLOCK trial[J]. BJU Int, 2022, 129(2): 217-224. DOI: 10.1111/bju.15503.
[38]
Xiong L, Nguyen JK, Peng Y, et al. What happens to the preserved renal parenchyma after clamped partial nephrectomy?[J]. Eur Urol, 2022, 81(5): 492-500. DOI: 10.1016/j.eururo.2021.12.036.
[39]
Tsivian M, Joyce DD, Packiam VT, et al. Unplanned conversion from partial to radical nephrectomy: an analysis of incidence, etiology, and risk factors[J]. J Urol, 2022, 208(5): 960-968. DOI: 10.1097/JU.0000000000002837.
[40]
周清臣, 张佳铖, 毕良宽, 等. 应用早期序贯开放血流法在后腹腔镜肾部分切除术治疗T1b期肾肿瘤中的疗效及安全性评估[J]. 实用医学杂志, 2019, 35(18): 2891-2894. DOI: 10.3969/j.issn.1006-5725.2019.18.013.
[41]
施展, 曲发军, 胡传义, 等. 早期开放血流技术在肾门部中央型肿瘤保留肾单位手术中的疗效分析[J]. 腹腔镜外科杂志, 2019, 24(11): 859-862. DOI: 10.13499/j.cnki.fqjwkzz.2019.11.859.
[42]
Yin X, Jiang S, Shao Z, et al. Kidney ventrally rotation technique in retroperitoneal robot-assisted partial nephrectomy for posterior hilar tumor: technical feasibility and preliminary results[J]. World J Surg Oncol, 2020, 18(1): 148. DOI: 10.1186/s12957-020-01928-2.
[43]
Liu L, Qi L, Li Y, et al. Retroperitoneoscopic partial nephrectomy for moderately complex ventral hilar tumors: surgical technique and trifecta outcomes from a single institution in China[J]. J Laparoendosc Adv Surg Tech A, 2017, 27(8): 812-817. DOI: 10.1089/lap.2016.0194.
[44]
陈杰, 徐必友, 徐丹枫, 等. 新型双向倒钩免打结缝合线在肾门部肿瘤腹腔镜下肾部分切除术中的应用[J]. 微创泌尿外科杂志, 2014, 3(2): 84-87. DOI:10.3969/j.issn.2095-5146.2014.02.006.
[45]
张崔建, 曹剑哲, 李学松, 等. 切缘环形缝合技术在肾部分切除术中的应用效果[J]. 中华外科杂志, 2015, 53(11): 852-855. DOI: 10.3760/cma.j.issn.0529-5815.2015.11.012.
[46]
Gao Y, Li H, Yao Y, et al. Vessel and tension-free reconstruction during robot-assisted partial nephrectomy for hilar tumors: "garland" technique and midterm outcomes[J]. J Endourol, 2020, 34(4): 469-474. DOI: 10.1089/end.2019.0792.
[47]
Khalifeh A, Autorino R, Hillyer SP, et al. V-hilar suture renorrhaphy during robotic partial nephrectomy for renal hilar tumors: preliminary outcomes of a novel surgical technique[J]. Urology, 2012, 80(2): 466-471. DOI: 10.1016/j.urology.2012.03.058.
[48]
Ramani AP, Desai MM, Steinberg AP, et al. Complications of laparoscopic partial nephrectomy in 200 cases[J]. J Urol, 2005, 173(1): 42-47. DOI: 10.1097/01.ju.0000147177.20458.73.
[49]
Lu SY, Chung HJ, Huang EY, et al. The perioperative outcomes between renal hilar and non-hilar tumors following robotic-assisted partial nephrectomy (RAPN)[J]. J Chin Med Assoc, 2018, 81(8): 676-681. DOI: 10.1016/j.jcma.2017.11.014.
[50]
王杰, 梁小龙, 吴震杰, 等. 机器人辅助腹腔镜肾部分切除术治疗高复杂性肾肿瘤(R.E.N.A.L.评分≥10分)经验总结[J]. 微创泌尿外科杂志, 2017, 6(1): 8-13. DOI: 10.19558/j.cnki.10-1020/r.2017.01.003.
[51]
Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European association of urology guidelines on renal cell carcinoma: the 2022 update[J]. Eur Urol, 2022, 82(4): 399-410. DOI: 10.1016/j.eururo.2022.03.006.
[52]
Correa AF, Yankey H, Li T, et al. Renal hilar lesions: biological implications for complex partial nephrectomy[J]. Urology, 2019, 123: 174-180. DOI: 10.1016/j.urology.2018.08.044.
[53]
Bahouth Z, Halachmi S, Getzler I, et al. Functional and oncological outcomes of open nephron-sparing surgery for complex renal masses[J]. Urol Oncol, 2015, 33(10): 427.e11-427.e16. DOI: 10.1016/j.urolonc.2015.04.016.
[1] 曾舒昊, 康博禹, 郑高赞, 郑建勇, 丰帆. 青年结直肠癌患者的临床病理特征及预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 449-452.
[2] 李盼, 张华秦. 不同腹腔镜胆囊切除术治疗胆囊结石的疗效比较研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(04): 388-391.
[3] 刘伟博, 李林, 张玉斌. ERAS理念下的经脐单孔腹腔镜胆囊切除术对患者术后恢复的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 278-281.
[4] 李鹏, 刘光世, 李涛. 基于黑色素瘤相关抗原A6在胃癌转移与预后的作用机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(03): 282-284.
[5] 薛一博, 景冠华, 徐豪, 张云天, 束坤鹏, 石红林. 雄激素剥夺治疗后PSA动态变化预测前列腺癌进展为去势抵抗性前列腺癌的价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(04): 454-459.
[6] 李博, 翟炜, 郑军华. CD70在肾细胞癌精准诊疗中的价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(04): 399-403.
[7] 陈琼, 吴卓龙, 黄吉炜. 免疫治疗在局部进展期肾癌围手术期治疗中的应用进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(04): 418-422.
[8] 叶孙益, 彭鼎, 汪朔, 夏丹. 单孔机器人与腹腔镜在保留肾单位肾部分切除术的小样本随机对照研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(04): 423-428.
[9] 薛一博, 景冠华, 徐豪, 张云天, 束坤鹏, 石红林. 雄激素剥夺治疗后PSA动态变化预测前列腺癌进展为去势抵抗性前列腺癌的价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(04): 454-459.
[10] 刘国路, 李乾, 王以金, 王苏贵, 胡好, 张璐. 甘油三酯-葡萄糖指数与肾细胞癌患者术后预后的关系[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(04): 492-497.
[11] 张辉, 林金铭, 郭高伟, 李鑫基, 张伟, 黄沛东, 郑长征, 陈晓生, 卢勇. 广东省医学会泌尿外科疑难病例多学科会诊(第17期)——右肾巨大肿瘤并腔静脉癌栓和髂血管血栓[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(04): 532-538.
[12] 王淼, 贺佳佳, 潘颖威, 王小兰, 姚袆, 刘明宝, 陆兮, 苏丽洁. 远端胆管癌术后生存预后及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 582-588.
[13] 刘晓萍, 汪嵘嵘, 吴佳慧, 吴紫云, 周伯宣. 多组学分析HAPLN1与肝癌预后及免疫细胞浸润关系[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 609-618.
[14] 郭勇, 贾思颖, 高士杰, 涂康生. RNFT2在肝细胞癌中表达及其对细胞增殖、侵袭和患者预后影响[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(04): 619-627.
[15] 袁伟, 郑肖肖, 李秀丽, 冯新红. 复杂腰骶神经根病的临床特征分析[J/OL]. 中华老年骨科与康复电子杂志, 2025, 11(04): 214-221.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?